PlexusDx vs Brello Health: GLP-1 Pricing and Plan Terms Compared

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Brello Health requires a $399 upfront charge for three months of compounded semaglutide injection or $499 every 11 weeks for tirzepatide injection. PlexusDx offers the same compounded injections at $189/month month-to-month for semaglutide and $289/month for tirzepatide, with no multi-month commitment required. Over 12 months, Brello's prepaid semaglutide plan costs $1,596 total ($133/month effective), while PlexusDx month-to-month costs $2,268 ($189/month). PlexusDx 6-month prepaid semaglutide costs $1,788 total ($149/month effective). For tirzepatide, Brello's 11-week cycle costs approximately $2,359 over 12 months ($196.58/month effective), while PlexusDx month-to-month costs $3,468 ($289/month) and 6-month prepaid costs $2,988 ($249/month effective). Brello wins on semaglutide if you can commit $399 upfront; PlexusDx offers greater plan flexibility, oral and microdose options, and lower tirzepatide costs on multi-month plans.

At-a-glance comparison

Sources: Brello Health pricing and plan terms verified at tirzepatidewoo.brellohealth.com and brellohealth.com/home1, September 4, 2026. PlexusDx pricing verified at plexusdx.com product pages, July 17–23, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Normalized 12-month cost comparison

Brello Health structures both semaglutide and tirzepatide as prepaid plans, while PlexusDx offers month-to-month and multi-month prepaid options. To compare fairly, we calculate the total cost over 12 months and the effective monthly rate for each plan. All derived figures below are our calculations based on the published rates.

Semaglutide injection: 12-month cost

Brello Health's 3-month prepaid semaglutide plan costs $1,596 over 12 months, an effective rate of $133 per month (our calculation). This is the lowest semaglutide cost in this comparison. PlexusDx 6-month prepaid semaglutide costs $1,788 over 12 months ($149/month effective, our calculation), $192 more than Brello over a year. PlexusDx month-to-month costs $2,268 over 12 months ($189/month), $672 more than Brello.

Upfront commitment: Brello requires $399 at signup and every three months thereafter. PlexusDx month-to-month requires $189 at signup, then $189 monthly; 3-month prepaid requires $507 upfront; 6-month prepaid requires $894 upfront.

Tirzepatide injection: 12-month cost

Brello Health's tirzepatide plan bills $499 every 11 weeks. Over 52 weeks (one year), this equals 4.727 billing cycles, for a total of $2,359 (our calculation). The effective monthly rate is $196.58 (our calculation). This is the lowest tirzepatide cost in this comparison.

PlexusDx 6-month prepaid tirzepatide costs $2,988 over 12 months ($249/month effective, our calculation), $629 more than Brello over a year. PlexusDx month-to-month costs $3,468 over 12 months ($289/month), $1,109 more than Brello.

Upfront commitment: Brello requires $499 at signup and every 11 weeks thereafter. PlexusDx month-to-month requires $289 at signup, then $289 monthly; 3-month prepaid requires $807 upfront; 6-month prepaid requires $1,494 upfront.

Note on Brello's advertised per-month figures: Brello advertises semaglutide at $133/month and tirzepatide at approximately $166/month. These are prepaid per-month equivalents calculated from the upfront charges ($399 ÷ 3 = $133 for semaglutide; $499 ÷ 3 = $166.33 for tirzepatide). The actual billing is $399 every 3 months for semaglutide and $499 every 11 weeks for tirzepatide. Over 12 months, tirzepatide's effective rate is higher than the advertised $166 figure because 11 weeks × 3 equals only 33 weeks (not 52 weeks).

Plan flexibility and cancellation terms

Brello Health and PlexusDx differ significantly in plan flexibility. Brello's semaglutide plan carries a three-month minimum commitment, meaning you must complete at least one $399 billing cycle before you can cancel. Brello's tirzepatide plan, by contrast, states "cancel anytime," though you still pay $499 upfront for each 11-week cycle.

PlexusDx offers month-to-month plans for all medications, with no multi-month commitment required. You may cancel at any time. PlexusDx also offers optional 3-month and 6-month prepaid plans at lower per-month rates; these require upfront payment for the full period but lock in the lower rate.

If you are uncertain about tolerating a GLP-1 or staying on treatment for three months, PlexusDx month-to-month offers greater flexibility at a higher per-month cost. If you are confident in a multi-month commitment, Brello's prepaid semaglutide plan offers the lowest effective monthly rate in this comparison.

Semaglutide cancellation caveat: Brello's semaglutide page states a three-month minimum but does not explicitly describe cancellation or refund terms beyond that minimum. We recommend confirming cancellation and refund policies at checkout before committing.

Product breadth: injections, oral, and microdose

Brello Health offers only compounded semaglutide and tirzepatide injections. PlexusDx offers the same injections plus oral semaglutide capsules ($289/month month-to-month), oral tirzepatide capsules ($349/month month-to-month), and a microdose GLP-1 injection protocol ($129/month month-to-month).

The oral formulations may appeal to patients who prefer not to inject or who have difficulty with subcutaneous injections. The microdose protocol is designed for maintenance, slower titration, or individuals seeking the metabolic and appetite benefits of GLP-1 at lower doses and lower cost.

If you know you want injectable semaglutide or tirzepatide and can commit upfront, Brello's prepaid plans are economically competitive. If you want to explore oral formulations, start with a microdose, or preserve month-to-month flexibility, PlexusDx offers those options within a single provider relationship.

Pricing transparency and dose consistency

Both Brello Health and PlexusDx publish single, all-inclusive prices that do not vary by dose. Neither provider charges a separate membership fee, consultation fee, or shipping fee on top of the medication price.

PlexusDx pricing is structured as a flat rate per plan type (month-to-month, 3-month, or 6-month) and does not increase as you titrate to higher doses. The same is true of Brello's prepaid plans: $399 for semaglutide and $499 for tirzepatide, regardless of dose level within the treatment period.

This pricing model differs from some competitors that adjust the monthly cost as dose increases, making long-term budgeting simpler for both Brello and PlexusDx patients.

Choose Brello Health if…

• You want the lowest effective monthly cost for compounded semaglutide ($133/month effective, $1,596 over 12 months) or tirzepatide ($196.58/month effective, $2,359 over 12 months).
• You can commit $399 upfront for semaglutide or $499 upfront for tirzepatide and prefer prepaid billing.
• You are confident in staying on injectable GLP-1 therapy for at least three months (semaglutide) or 11 weeks per cycle (tirzepatide).
• You do not need oral formulations, microdose options, or month-to-month flexibility.

Choose PlexusDx if…

• You want month-to-month flexibility with no multi-month commitment required, especially while assessing tolerance or efficacy.
• You prefer a lower upfront cost ($189 for semaglutide month-to-month vs. $399 for Brello's 3-month plan; $289 for tirzepatide month-to-month vs. $499 for Brello's 11-week plan).
• You want access to oral semaglutide or tirzepatide capsules, which Brello does not offer.
• You are interested in a microdose GLP-1 protocol for maintenance or cautious titration at $129/month.
• You value a single provider relationship that offers injectable, oral, and microdose options without switching services.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026).

Methodology and freshness

Brello Health pricing, plan terms, and product offerings were verified at tirzepatidewoo.brellohealth.com and brellohealth.com/home1 on September 4, 2026. PlexusDx pricing was verified at plexusdx.com product pages between July 17 and July 23, 2026. PlexusDx Trustpilot rating was captured September 4, 2026.

The 12-month cost totals and effective monthly rates are our calculations, derived by multiplying published rates by the number of billing cycles in 12 months. Brello's tirzepatide 12-month cost assumes 52 weeks ÷ 11 weeks per cycle = 4.727 cycles × $499 = $2,359 total. Brello's semaglutide 12-month cost assumes 4 quarters × $399 = $1,596 total. PlexusDx 12-month costs are calculated by multiplying the per-month rate by 12 or the per-cycle rate by the number of cycles in 12 months.

No promotional codes, first-month discounts, or referral incentives were observed for either provider during evidence capture. Pricing may change; confirm all figures at checkout.

Frequently Asked Questions

Does Brello Health require a membership fee on top of medication cost?

No. Brello Health advertises all-inclusive pricing with no separate membership, consultation, or service fee. The $399 (semaglutide) or $499 (tirzepatide) charge covers medication, provider visit, and shipping.

Can I switch from Brello to PlexusDx or vice versa mid-treatment?

Switching providers mid-treatment is possible but depends on dose records, prescription continuity, and each provider's transfer policies. Neither Brello nor PlexusDx guarantees acceptance of transfers. Confirm transfer and dose-continuation policies with the receiving provider before canceling your current plan.

Why is Brello's tirzepatide billed every 11 weeks instead of monthly?

Brello structures tirzepatide as a prepaid 11-week (approximately 3-month) supply, similar to its semaglutide 3-month structure. This billing cycle does not align with calendar months, so over a full year you will be billed 4.727 times (our calculation), resulting in an effective monthly cost of $196.58 rather than the advertised $166 figure.

Does PlexusDx charge more per month as I titrate to higher doses?

No. PlexusDx publishes one flat rate per plan type (month-to-month, 3-month, or 6-month) that does not increase with dose. You pay the same monthly rate at 0.25 mg as you do at 2.4 mg for semaglutide, and the same applies to tirzepatide dose progression.

Which provider is better if I am unsure I can tolerate GLP-1 injections?

PlexusDx month-to-month offers greater flexibility for first-time GLP-1 users. You can start at $189/month for semaglutide with no multi-month commitment and cancel anytime. Brello requires $399 upfront for a three-month semaglutide commitment, which is a larger financial exposure if you discontinue early due to side effects or non-response.

Sources

• Brello Health semaglutide and tirzepatide pricing, plan terms, and product offerings: tirzepatidewoo.brellohealth.com and brellohealth.com/home1 (accessed September 4, 2026)
• PlexusDx semaglutide injection, tirzepatide injection, oral, and microdose pricing: plexusdx.com product pages (accessed July 17–23, 2026)
• PlexusDx Trustpilot rating: trustpilot.com/review/plexusdx.com (accessed September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.